Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV)

Latest Posts

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Study details economic impact of RSV infections in young children

May 24, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Studies estimate 75% RSV vaccine efficacy in older adults, profile risk for poor outcomes

May 14, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Hospital admissions of respiratory infections in infants plunge with nirsevimab RSV antibody

May 10, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

RSV studies identify risk factors in older adults, household transmission routes

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Study shows nirsevimab provides significant protection against RSV

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Nirsevimab estimated at 64% to 74% effective against poor RSV outcomes in infants

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Reports describe good maternal RSV vaccine, drug uptake in their first season

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

UK study finds 2% of primary care antibiotic prescriptions were for RSV—a viral illness

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

RSV vaccine prompts robust immune response in older recipients over 2 seasons

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

US flu activity climbs, with more deaths in kids

April 4, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

HEPA purifiers not tied to less viral exposure in elementary classrooms, analysis finds

October 14, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Data: Pediatric hospital strain amid 2022-23 respiratory virus season not tied to decline in beds

October 9, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Cochrane review shows RSV vaccines safe, effective

October 1, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Trial finds clesrovimab 60% effective in preventing RSV in infants

September 23, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Study highlights elevated rates of hospitalization, ICU care, death in older RSV patients

September 19, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Report: Kids with severe RSV at higher risk for hospitalization than those with HMPV

August 27, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

New ACC guidance urges uptake of 5 vaccines for heart patients

August 27, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Researchers note high burden of RSV on older US adults before vaccine availability

August 27, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Vaccine Integrity Project presents reassuring data on vaccines for upcoming respiratory virus season

August 21, 2025

Cidrap EDU, Respiratory Syncytial Virus (RSV), RSS

Timing of maternal vaccination, nirsevimab to avert RSV in infants may influence cost-effectiveness

August 8, 2025